Abstract
Background: First episode genital herpes simplex virus (HSV) infections can be classified into three groups, primary genital herpes (no previous exposure to HSV), non-primary first episode (IgG antibody to HSV of the non-presenting type), and first episode with pre-existing IgG HSV antibodies. The use of IgM to classify first episode genital herpes has not been evaluated.
Objective: To evaluate the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of HSV-1 and HSV-2 IgM antibodies for the diagnosis of first episode genital herpes, when compared with clinical diagnosis.
Methods: Patients with a first clinical episode of genital herpes were recruited. Sera were tested for IgG antibodies to HSV-2 using an indirect enzyme linked immunosorbent assay (ELISA). Equivocal results were resolved by western blot. HSV-1 IgG and IgM and HSV-2 IgM antibodies were detected using western blot.
Results: 157 patients were recruited. 31 were excluded (missing data or no detectable antibodies and negative viral isolation). Therefore, 126 patients were included in the analysis. 23 (18.3%) had primary genital herpes, 34 (27.0%) non-primary first episode, and 69 (54.8%) had pre-existing genital herpes. The specificity and PPV of HSV IgM was 100%; the sensitivity was 79% and the NPV 85%.
Conclusion: IgM HSV serology may be useful in the management of some patients with first episode genital herpes and provide an indication of the source of infection. Drawbacks include the low sensitivity and NPV, lack of availability, IgM antibodies may occasionally be produced in response to recurrent infection and, finally, IgM antibodies may take up to 10 days to develop and last 7–10 days.
Full Text
The Full Text of this article is available as a PDF (139.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ashley R. L., Corey L. HSV type specific antibody tests: patients are ready, are clinicians? Genitourin Med. 1997 Aug;73(4):235–236. doi: 10.1136/sti.73.4.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ashley R. L., Militoni J., Lee F., Nahmias A., Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol. 1988 Apr;26(4):662–667. doi: 10.1128/jcm.26.4.662-667.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Corey L., Adams H. G., Brown Z. A., Holmes K. K. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med. 1983 Jun;98(6):958–972. doi: 10.7326/0003-4819-98-6-958. [DOI] [PubMed] [Google Scholar]
- Corey L., Spear P. G. Infections with herpes simplex viruses (1). N Engl J Med. 1986 Mar 13;314(11):686–691. doi: 10.1056/NEJM198603133141105. [DOI] [PubMed] [Google Scholar]
- Diamond C., Selke S., Ashley R., Benedetti J., Corey L. Clinical course of patients with serologic evidence of recurrent genital herpes presenting with signs and symptoms of first episode disease. Sex Transm Dis. 1999 Apr;26(4):221–225. doi: 10.1097/00007435-199904000-00007. [DOI] [PubMed] [Google Scholar]
- Ho D. W., Field P. R., Irving W. L., Packham D. R., Cunningham A. L. Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. J Clin Microbiol. 1993 Dec;31(12):3157–3164. doi: 10.1128/jcm.31.12.3157-3164.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ho D. W., Field P. R., Sjögren-Jansson E., Jeansson S., Cunningham A. L. Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J Virol Methods. 1992 Mar;36(3):249–264. doi: 10.1016/0166-0934(92)90056-j. [DOI] [PubMed] [Google Scholar]
- Koutsky L. A., Ashley R. L., Holmes K. K., Stevens C. E., Critchlow C. W., Kiviat N., Lipinski C. M., Wølner-Hanssen P., Corey L. The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex Transm Dis. 1990 Apr-Jun;17(2):90–94. doi: 10.1097/00007435-199004000-00009. [DOI] [PubMed] [Google Scholar]
- Langenberg A., Benedetti J., Jenkins J., Ashley R., Winter C., Corey L. Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection. Ann Intern Med. 1989 Jun 1;110(11):882–887. doi: 10.7326/0003-4819-110-11-882. [DOI] [PubMed] [Google Scholar]
- Mindel A., Estcourt C. Public and personal health implications of asymptomatic viral shedding in genital herpes. Sex Transm Infect. 1998 Dec;74(6):387–389. [PubMed] [Google Scholar]
- Slomka M. J., Ashley R. L., Cowan F. M., Cross A., Brown D. W. Monoclonal antibody blocking tests for the detection of HSV-1- and HSV-2-specific humoral responses: comparison with western blot assay. J Virol Methods. 1995 Sep;55(1):27–35. doi: 10.1016/0166-0934(95)00042-s. [DOI] [PubMed] [Google Scholar]
- Stanberry L., Cunningham A., Mertz G., Mindel A., Peters B., Reitano M., Sacks S., Wald A., Wassilew S., Woolley P. New developments in the epidemiology, natural history and management of genital herpes. Antiviral Res. 1999 May;42(1):1–14. doi: 10.1016/s0166-3542(99)00004-2. [DOI] [PubMed] [Google Scholar]
- Wald A., Langenberg A. G., Link K., Izu A. E., Ashley R., Warren T., Tyring S., Douglas J. M., Jr, Corey L. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA. 2001 Jun 27;285(24):3100–3106. doi: 10.1001/jama.285.24.3100. [DOI] [PubMed] [Google Scholar]